ETF Holdings Breakdown of VYGR

Stock Name	Voyager Therapeutics Inc
Ticker	VYGR(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92915B1061
LEI	54930082S4XVR0ZWCC74

VYGR institutional holdings

The following institutional investment holdings of VYGR have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 33,147 USD 140,875 4.25

2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 33,147 0.3% USD 140,875 0.0% 4.25

Total = 66,294 USD 281,750
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	33,147	USD 140,875	4.25
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	33,147 0.3%	USD 140,875 0.0%	4.25
Total =	66,294	USD 281,750

News associated with VYGR

HC Wainwright Reiterates “Buy” Rating for Voyager Therapeutics (NASDAQ:VYGR): Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $30.00 target price on the stock. Separately, Wedbush lowered their price objective on Voyager Therapeutics from $9.00 to $8.00 and set an “outperform” rating […] - 2025-09-17 02:30:53
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of “Buy” from Brokerages: Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month […] - 2025-07-30 02:46:52
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39: Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […] - 2025-07-08 02:38:54
Voyager Therapeutics (NASDAQ:VYGR) and Prime Medicine (NYSE:PRME) Head-To-Head Contrast: Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) and Prime Medicine (NYSE:PRME – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 48.0% of Voyager […] - 2025-06-18 02:26:52
Analysts Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39: Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year […] - 2025-06-13 02:32:50
BNP Paribas Financial Markets Trims Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR): BNP Paribas Financial Markets decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 87.8% in the fourth quarter, Holdings Channel reports. The firm owned 6,025 shares of the company’s stock after selling 43,210 shares during the period. BNP Paribas Financial Markets’ holdings in Voyager Therapeutics were worth $34,000 at the end of […] - 2025-06-05 04:18:54
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Deutsche Bank AG: Deutsche Bank AG trimmed its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 45.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 42,470 shares of the company’s stock after selling 35,898 shares during the period. Deutsche Bank AG’s holdings in Voyager Therapeutics were worth $241,000 at the end of the […] - 2025-06-02 04:42:59
State of Wyoming Trims Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR): State of Wyoming decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 36.8% during the fourth quarter, Holdings Channel reports. The fund owned 8,904 shares of the company’s stock after selling 5,191 shares during the period. State of Wyoming’s holdings in Voyager Therapeutics were worth $50,000 as of its most recent filing […] - 2025-05-30 05:08:56
Man Group plc Purchases New Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR): Man Group plc acquired a new position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 41,200 shares of the company’s stock, valued at approximately $234,000. Man Group plc owned 0.08% of Voyager Therapeutics […] - 2025-05-28 05:00:56
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $13.39 Consensus PT from Brokerages: Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-19 02:32:50
Legal & General Group Plc Acquires 7,597 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR): Legal & General Group Plc lifted its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 65.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 19,245 shares of the company’s stock after buying an additional 7,597 shares during the period. Legal & General Group Plc’s holdings in Voyager Therapeutics were worth […] - 2025-05-02 04:30:49
XTX Topco Ltd Invests $178,000 in Voyager Therapeutics, Inc. (NASDAQ:VYGR): XTX Topco Ltd bought a new position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 31,375 shares of the company’s stock, valued at approximately $178,000. Other hedge funds have also recently modified their holdings of the company. Picton Mahoney Asset Management grew its […] - 2025-04-29 05:00:58
Wellington Management Group LLP Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR): Wellington Management Group LLP raised its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 13.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 261,251 shares of the company’s stock after acquiring an additional 31,882 shares during the […] - 2025-04-14 04:50:52
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR): Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $30.00 price target on the stock. VYGR has been the subject of a number of other reports. StockNews.com cut shares of Voyager Therapeutics from a […] - 2025-04-10 02:58:47
Bank of New York Mellon Corp Cuts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR): Bank of New York Mellon Corp lessened its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 193,315 shares of the company’s stock after selling 56,213 shares during the period. Bank of New York Mellon Corp’s holdings […] - 2025-03-25 05:14:53
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $15.72 Average Price Target from Analysts: Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price […] - 2025-03-05 04:20:51
Allspring Global Investments Holdings LLC Buys 7,573 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR): Allspring Global Investments Holdings LLC boosted its position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 23.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 39,313 shares of the company’s stock after acquiring an additional 7,573 shares during […] - 2025-02-26 06:42:54
Voyager Therapeutics (NASDAQ:VYGR) Receives “Outperform” Rating from Wedbush: Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report published on Tuesday morning,RTT News reports. Wedbush currently has a $9.00 price target on the stock, down from their prior price target of $11.00. Several other brokerages have also recently issued reports on VYGR. Cantor Fitzgerald started coverage […] - 2025-02-12 07:14:56

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.